Advertisement

Megaprosthesis for Metastasis of the Lower Limb

  • Carmine Zoccali
  • Dario Attala
  • Alessandra Scotto
  • Roberto Biagini
Chapter

Abstract

In the past, the surgical approach to bone metastasis had the sole purpose to solve a biomechanical problem because the patient would die for systemic disease progression. Intramedullary nailing was the mainstay of the treatment, and its aim was allowing the patient to stand, with local tumor control achieved by radiotherapy [1, 2]. The improvement of medical therapy, radiotherapy and new diagnostic techniques have led to an increment of global life expectancy in bone metastatic patients, so complications related to the first surgery, often requiring further surgeries, are more common (Fig.1) [3, 5].Today, the surgeon has to take the possibility of a long survival into account, moreover if the patient has just one bone metastatic disease; this means performing more resections with wide margins and prosthetic reconstruction than before [6].Resection has to be considered after taking account of several factors which have to be evaluated from a multidisciplinary point of view and considering life expectancy: the oncologist, the orthopedic surgeon, the pathologist, the radiotherapist and the anesthesiologist are the main protagonists. The final decision has to be taken by the patient, once correctly informed about advantages and disadvantages of the possible procedures [7].

References

  1. 1.
    Durandeau A, Geneste R. Surgical treatment of metastatic fractures and metastases of the long bones. Apropos of 73 cases. Rev Chir Orthop Reparatrice Appar Mot. 1977;63(5):501–17.PubMedGoogle Scholar
  2. 2.
    Futani H, Kamae S, Atsui K, Yoh K, Tateishi H, Maruo S. Successful limb salvage of pathological fracture of the distal tibia caused by cancer metastasis. J Orthop Sci. 2002;7(2):262–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20 Pt 2):6243s–9s.CrossRefPubMedGoogle Scholar
  4. 4.
    Forsberg JA, Eberhardt J, Boland PJ, Wedin R, Healey JH. Estimating survival in patients with operable skeletal metastases: an application of a Bayesian belief network. PLoS One. 2011;6:e19956.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Gao H, Liu Z, Wang B, Guo A. Clinical and functional comparison of endoprosthetic replacement with intramedullary nailing for treating proximal femur metastasis. Chin J Cancer Res. 2016;28(2):209–14.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Nathan SS, Healey JH, Mellano D, Hoang B, Lewis I, Morris CD, et al. Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care. J Clin Oncol. 2005;23(25):6072–82.CrossRefPubMedGoogle Scholar
  7. 7.
    Chan D, Carter SR, Grimer RJ, Sneath RS. Endoprosthetic replacement for bony metastases. Ann R Coll Surg Engl. 1992;74:13–8.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Bauer HC, Wedin R. Survival after surgery for spinal and extremity metastases: prognostication in 241 patients. Acta Orthop Scand. 1995;66:143–6.CrossRefPubMedGoogle Scholar
  9. 9.
    Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer. 1987;55:61–6.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.CrossRefPubMedGoogle Scholar
  11. 11.
    Masutani M, Tsujino I, Fujie T, Yamaguchi M, Miyagi K, Yano T, et al. Moderate dose-intensive chemotherapy for patients with non-small cell lung cancer: randomized trial, can it improve survival of patients with good performance status? Oncol Rep. 1999;6(5):1045–50.PubMedGoogle Scholar
  12. 12.
    Mani S, Todd MB, Katz K, Poo WJ. Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers. J Urol. 1995;154(1):35–40.CrossRefPubMedGoogle Scholar
  13. 13.
    Bohm P, Huber J. The surgical treatment of bony metastases of the spine and limbs. J Bone Joint Surg Br. 2002;84:521–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Mirels H. Metastatic disease in long bones: a proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res. 2003;415(Suppl):S4–13.CrossRefGoogle Scholar
  15. 15.
    Zacherl M, Gruber G, Glehr M, Ofner-Kopeinig P, Radl R, Greitbauer M, et al. Surgery for pathological proximal femoral fractures, excluding femoral head and neck fractures: resection vs. stabilisation. Int Orthop. 2011;35(10):1537–43.CrossRefPubMedGoogle Scholar
  16. 16.
    Camnasio F, Scotti C, Peretti GM, Fontana F, Fraschini G. Prosthetic joint replacement for long bone metastases: analysis of 154 cases. Arch Orthop Trauma Surg. 2008;128(8):787–93.CrossRefPubMedGoogle Scholar
  17. 17.
    Kapoor SK, Thiyam R. Management of infection following reconstruction in bone tumors. J Clin Orthop Trauma. 2015;6(4):244–51.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Rossi B, Zoccali C, Toma L, Ferraresi V, Biagini R. Surgical site infections in treatment of musculoskeletal tumors: experience from a single oncologic orthopedic institution. J Orthop Oncol. 2016;2:108.CrossRefGoogle Scholar
  19. 19.
    Bischel OE, Böhm PM. The use of a femoral revision stem in the treatment of primary or secondary bone tumours of the proximal femur: a prospective study of 31 cases. J Bone Joint Surg Br. 2010;92(10):1435–41.CrossRefPubMedGoogle Scholar
  20. 20.
    Campanacci M. Bone and soft tissue tumors. New York: Springer; 1999.CrossRefGoogle Scholar
  21. 21.
    Gosheger G, Hillmann A, Lindner N, Rödl R, Hoffmann C, Bürger H, et al. Soft tissue reconstruction of megaprostheses using a trevira tube. Clin Orthop Relat Res. 2001;393:264–71.CrossRefGoogle Scholar
  22. 22.
    Guzik G. Results of the treatment of bone metastases with modular prosthetic replacement-analysis of 67 patients. J Orthop Surg Res. 2016;11(1):20.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Henrichs MP, Krebs J, Gosheger G, Streitbuerger A, Nottrott M, Sauer T, et al. Modular tumor endoprostheses in surgical palliation of long-bone metastases: a reduction in tumor burden and a durable reconstruction. World J Surg Oncol. 2014;12:330.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Chandrasekar CR, Grimer RJ, Carter SR, Tillman RM, Abudu A, Buckley L. Modular endoprosthetic replacement for tumours of the proximal femur. J Bone Joint Surg Br. 2009;91(1):108–12.CrossRefPubMedGoogle Scholar
  25. 25.
    Haentjens P, de Neve W, Casteleyn PP, Opdecam P. Massive resection and prosthetic replacement for the treatment of metastases of the trochanteric and subtrochanteric femoral region bipolar arthroplasty versus total hip arthroplasty. Acta Orthop Belg. 1993;59(Suppl 1):367–71.PubMedGoogle Scholar
  26. 26.
    Cho HS, Lee YK, Ha YC, Koo KH. Trochanter/calcar preserving reconstruction in tumors involving the femoral head and neck. World J Orthop. 2016;7(7):442–7.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Manoso MW, Frassica DA, Lietman ES, Frassica FJ. Proximal femoral replacement for metastatic bone disease. Orthopedics. 2007;30(5):384–8.PubMedGoogle Scholar
  28. 28.
    Calabró T, Van Rooyen R, Piraino I, Pala E, Trovarelli G, Panagopoulos GN, et al. Reconstruction of the proximal femur with a modular resection prosthesis. Eur J Orthop Surg Traumatol. 2016;26(4):415–21.CrossRefPubMedGoogle Scholar
  29. 29.
    Winkelmann W. Reconstruction of the proximal femur with the MUTARS® system. Orthopade. 2010;39(10):942–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Benevenia J, Kirchner R, Patterson F, Beebe K, Wirtz DC, Rivero S, et al. Outcomes of a modular intercalary endoprosthesis as treatment for segmental defects of the femur, tibia, and humerus. Clin Orthop Relat Res. 2016;474:549–50.CrossRefGoogle Scholar
  31. 31.
    Pala E, Trovarelli G, Calabrò T, Angelini A, Abati CN, Ruggieri P. Survival of modern knee tumor megaprostheses: failures, functional results, and a comparative statistical analysis. Clin Orthop Relat Res. 2015;473(3):891–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Pala E, Trovarelli G, Angelini A, Ruggieri P. Distal femur reconstruction with modular tumour prostheses: a single institution analysis of implant survival comparing fixed versus rotating hinge knee prostheses. Int Orthop. 2016;40(10):2171–80.CrossRefPubMedGoogle Scholar
  33. 33.
    Sewell MD, Hanna SA, McGrath A, Aston WJ, Blunn GW, Pollock RC, et al. Intercalary diaphyseal endoprosthetic reconstruction for malignant tibial bone tumours. J Bone Joint Surg Br. 2011;93(8):1111–7.CrossRefPubMedGoogle Scholar
  34. 34.
    Shekkeris AS, Hanna SA, Sewell MD, Spiegelberg BG, Aston WJ, Blunn GW, et al. Endoprosthetic reconstruction of the distal tibia and ankle joint after resection of primary bone tumours. J Bone Joint Surg Br. 2009;91(10):1378–82.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Carmine Zoccali
    • 1
  • Dario Attala
    • 1
  • Alessandra Scotto
    • 2
  • Roberto Biagini
    • 1
  1. 1.Oncological OrtopedicsRegina Elena National Cancer InstituteRomeItaly
  2. 2.School of MedicineTor Vergata UniversityRomeItaly

Personalised recommendations